Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg

A Critical Treatment for Chronic Liver Diseases in India

Related Keywords

South Africa ,Ahmedabad ,Gujarat ,India ,Mumbai ,Maharashtra ,Hindustan ,India General ,Sujatha Rajesh ,Sharvil Patel ,Asia Pacific ,Nilesh Gupta ,Corporate Communications Sustainability ,Lupin Limited ,Biotechnology Pharmaceuticals ,Zydus Lifesciences ,Zydus Lifesciences Ltd ,Business Wire ,Non Alcoholic Fatty Liver Disease ,Non Alcoholic Steato Hepatitis ,Lifesciences Limited ,Diabetes Mellitus ,Managing Director ,Alcoholic Liver Disease ,Non Alcoholic Steatohepatitis ,Latin America ,Middle East ,Great Place ,Vice President ,Corporate Communications ,Hindustan Times ,Whatsapp Channels ,Zydus ,Lupin ,Licensing Agreement ,Saroglitazar Mg ,